ENDRA Life Sciences Inc.
3600 Green Court, Suite 350
Ann Arbor, MI 48105
September 11, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tim Buchmiller
Re:
ENDRA Life Sciences Inc.
Registration Statement on Form S-3
File No. 333-233466
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant ENDRA Life Sciences Inc. hereby respectfully requests that the above-referenced Registration Statement on Form S-3 be declared effective at 4:00 p.m., Eastern Time, on Friday, September 13, 2019, or as soon thereafter as is practicable.
Please direct any questions regarding this request to Mark Busch of K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com). In addition, please notify Mr. Busch when this request for acceleration has been granted.
Sincerely,
/s/ David Wells
David Wells
Chief Financial Officer
